BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25538773)

  • 1. Role of protein phosphatases inhibitors on the histamine release and the functional desensitization in human lung mast cells.
    Bastan R; Eskandari N; Sabzghabaee AM; Esfahani SH; Peachell PT
    J Res Med Sci; 2014 Oct; 19(10):923-7. PubMed ID: 25538773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of receptor reserve on beta-adrenoceptor-mediated responses in human lung mast cells.
    Drury DE; Chong LK; Ghahramani P; Peachell PT
    Br J Pharmacol; 1998 Jun; 124(4):711-8. PubMed ID: 9690863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection by dexamethasone of the functional desensitization to beta 2-adrenoceptor-mediated responses in human lung mast cells.
    Chong LK; Drury DE; Dummer JF; Ghahramani P; Schleimer RP; Peachell PT
    Br J Pharmacol; 1997 Jun; 121(4):717-22. PubMed ID: 9208139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desensitization of beta2-adrenoceptor-mediated responses by short-acting beta2-adrenoceptor agonists in human lung mast cells.
    Chong LK; Suvarna K; Chess-Williams R; Peachell PT
    Br J Pharmacol; 2003 Feb; 138(3):512-20. PubMed ID: 12569076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of genetic polymorphisms in the beta2-adrenoceptor on desensitization in human lung mast cells.
    Chong LK; Chowdry J; Ghahramani P; Peachell PT
    Pharmacogenetics; 2000 Mar; 10(2):153-62. PubMed ID: 10762003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salmeterol inhibition of mediator release from human lung mast cells by beta-adrenoceptor-dependent and independent mechanisms.
    Chong LK; Cooper E; Vardey CJ; Peachell PT
    Br J Pharmacol; 1998 Mar; 123(5):1009-15. PubMed ID: 9535032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desensitisation of mast cell beta2-adrenoceptor-mediated responses by salmeterol and formoterol.
    Scola AM; Chong LK; Suvarna SK; Chess-Williams R; Peachell PT
    Br J Pharmacol; 2004 Jan; 141(1):163-71. PubMed ID: 14662724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of fostriecin on β2-adrenoceptor-driven responses in human mast cells.
    Bastan R; Eskandari N; J Ardakani H; T Peachell P
    J Immunotoxicol; 2017 Dec; 14(1):60-65. PubMed ID: 28090813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of agonist intrinsic activity on the desensitisation of beta2-adrenoceptor-mediated responses in mast cells.
    Scola AM; Chong LK; Chess-Williams R; Peachell PT
    Br J Pharmacol; 2004 Sep; 143(1):71-80. PubMed ID: 15289287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional desensitization of beta agonist responses in human lung mast cells.
    Chong LK; Morice AH; Yeo WW; Schleimer RP; Peachell PT
    Am J Respir Cell Mol Biol; 1995 Nov; 13(5):540-6. PubMed ID: 7576689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-adrenoceptor-mediated inhibition of mediator release from human peripheral blood-derived mast cells.
    Wang XS; Lau HY
    Clin Exp Pharmacol Physiol; 2006 Aug; 33(8):746-50. PubMed ID: 16895550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of beta2-adrenoceptor gene polymorphisms on beta2-adrenoceptor-mediated responses in human lung mast cells.
    Kay LJ; Rostami-Hodjegan A; Suvarna SK; Peachell PT
    Br J Pharmacol; 2007 Oct; 152(3):323-31. PubMed ID: 17643132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-adrenoceptor reserve in human lung: a comparison between airway smooth muscle and mast cells.
    Chong LK; Peachell PT
    Eur J Pharmacol; 1999 Jul; 378(1):115-22. PubMed ID: 10478571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of beta2-adrenoceptor desensitization on the IgE-dependent release of chemical mediators from cultured human mast cells.
    Tsuji T; Kato T; Kimata M; Miura T; Serizawa I; Inagaki N; Nagai H
    Biol Pharm Bull; 2004 Oct; 27(10):1549-54. PubMed ID: 15467193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary characterization of the role of protein serine/threonine phosphatases in the regulation of human lung mast cell function.
    Peirce MJ; Cox SE; Munday MR; Peachell PT
    Br J Pharmacol; 1997 Jan; 120(2):239-46. PubMed ID: 9117116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bidirectional Counterregulation of Human Lung Mast Cell and Airway Smooth Muscle β2 Adrenoceptors.
    Lewis RJ; Chachi L; Newby C; Amrani Y; Bradding P
    J Immunol; 2016 Jan; 196(1):55-63. PubMed ID: 26608913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of human lung mast cell function by phosphatase inhibitors.
    Peachell PT; Munday MR
    J Immunol; 1993 Oct; 151(7):3808-16. PubMed ID: 7690815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterisation of the beta-adrenoceptor expressed by human lung mast cells.
    Chong LK; Chess-Williams R; Peachell PT
    Eur J Pharmacol; 2002 Feb; 437(1-2):1-7. PubMed ID: 11864632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the thr164ile polymorphism in the beta2-adrenoceptor on the effects of beta-adrenoceptor agonists on human lung mast cells.
    Kay LJ; Chong LK; Rostami-Hodjegan A; Peachell PT
    Int Immunopharmacol; 2003 Jan; 3(1):91-5. PubMed ID: 12538038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-acting beta-adrenoceptor agonist, indacaterol, inhibits IgE-dependent responses of human lung mast cells.
    Scola AM; Loxham M; Charlton SJ; Peachell PT
    Br J Pharmacol; 2009 Sep; 158(1):267-76. PubMed ID: 19371332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.